<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="rapid-communication">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">WMqnHJGxmy39Hs5yFGnT8zL</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2012001400012</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(12)09900512</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2012001400012</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Comunica&#231;&#227;o Breve</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Valida&#231;&#227;o da vers&#227;o curta do question&#225;rio Rose de angina no Brasil</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Bastos</surname>
            <given-names>Maria-Socorro</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lotufo</surname>
            <given-names>Paulo A.</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Whitaker</surname>
            <given-names>Aristarcho L.</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bensenor</surname>
            <given-names>Isabela M.</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
      </contrib-group>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="city">Bel&#233;m</named-content>
          <named-content content-type="state">Par&#225;</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade Federal do Par&#225;</institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff03">
        <addr-line>
          <named-content content-type="city">S&#227;o Paulo</named-content>
          <named-content content-type="state">S&#227;o Paulo</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade de S&#227;o Paulo</institution>
        <institution content-type="orgdiv1">Faculdade de Medicina </institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff02">
        <addr-line>
          <named-content content-type="city">S&#227;o Paulo</named-content>
          <named-content content-type="state">S&#227;o Paulo</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade de S&#227;o Paulo</institution>
        <institution content-type="orgdiv1">Hospital Universit&#225;rio </institution>
        <country country="BR">Brazil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>11</month>
        <year>2012</year>
      </pub-date>
      <volume>99</volume>
      <issue>5</issue>
      <fpage>1056</fpage>
      <lpage>1059</lpage>
      <history>
        <date date-type="received">
          <day>21</day>
          <month>01</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>06</day>
          <month>07</month>
          <year>2012</year>
        </date>
        <date date-type="rev-recd">
          <day>24</day>
          <month>01</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>FUNDAMENTO: A angina pectoris est&#225;vel &#233; uma condi&#231;&#227;o grave com poucos estudos epidemiol&#243;gicos no Brasil. OBJETIVO: Validar a vers&#227;o curta do question&#225;rio Rose de angina em portugu&#234;s do Brasil para seu uso em pesquisas e estudos longitudinais. M&#201;TODOS: Foi recrutado um total de 116 pacientes consecutivos de uma cl&#237;nica ambulatorial sem hist&#243;rico de infarto do mioc&#225;rdio e/ou revasculariza&#231;&#227;o coronariana para a aplica&#231;&#227;o de tr&#234;s quest&#245;es do question&#225;rio Rose, abordando dor no peito ap&#243;s esfor&#231;o. Utilizamos como padr&#227;o-ouro o teste em esteira ergom&#233;trica com o protocolo Ellestad. RESULTADOS: A vers&#227;o curta do question&#225;rio Rose de angina dos 116 indiv&#237;duos submetidos ao teste de esfor&#231;o em esteira ergom&#233;trica mostrou 89,7% de acur&#225;cia, 25% de sensibilidade, 92% de especificidade, 10% de valor preditivo positivo, 97,2% de valor preditivo negativo e 3,1 de raz&#227;o de probabilidade positiva e 0,82 de raz&#227;o de probabilidade negativa. CONCLUS&#195;O: A vers&#227;o em portugu&#234;s com os tr&#234;s itens do question&#225;rio Rose de angina &#233; adequada para objetivos epidemiol&#243;gicos.</p>
      </abstract>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>Question&#225;rios</kwd>
        <kwd>angina pectoris</kwd>
        <kwd>doen&#231;as cardiovasculares</kwd>
        <kwd>doen&#231;a da art&#233;ria coronariana</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>22</day>
        <month>11</month>
        <year>2012</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>
      <bold>COMUNICA&#199;&#195;O BREVE</bold>
    </p>
    <p>Valida&#231;&#227;o da vers&#227;o curta do question&#225;rio Rose de angina no Brasil</p>
    <p>
      <bold>Maria-Socorro Bastos<sup>I</sup>; Paulo A. Lotufo<sup>II, III</sup>; Aristarcho L. Whitaker<sup>II</sup>; Isabela M. Bensenor<sup>II, III</sup></bold>
    </p>
    <p><sup>I</sup>Universidade Federal do Par&#225;, Bel&#233;m, PA - Brasil </p>
    <p><sup>II</sup>Hospital Universit&#225;rio da USP, S&#227;o Paulo, SP - Brasil </p>
    <p><sup>III</sup>Faculdade de Medicina da USP, S&#227;o Paulo, SP - Brasil</p>
    <p>
      <xref ref-type="corresp" rid="end">Correspond&#234;ncia</xref>
    </p>
    <p>
      <bold>RESUMO</bold>
    </p>
    <p><bold>FUNDAMENTO:</bold> A angina <italic>pectoris</italic> est&#225;vel &#233; uma condi&#231;&#227;o grave com poucos estudos epidemiol&#243;gicos no Brasil. </p>
    <p><bold>OBJETIVO:</bold> Validar a vers&#227;o curta do question&#225;rio Rose de angina em portugu&#234;s do Brasil para seu uso em pesquisas e estudos longitudinais. </p>
    <p><bold>M&#201;TODOS:</bold> Foi recrutado um total de 116 pacientes consecutivos de uma cl&#237;nica ambulatorial sem hist&#243;rico de infarto do mioc&#225;rdio e/ou revasculariza&#231;&#227;o coronariana para a aplica&#231;&#227;o de tr&#234;s quest&#245;es do question&#225;rio Rose, abordando dor no peito ap&#243;s esfor&#231;o. Utilizamos como padr&#227;o-ouro o teste em esteira ergom&#233;trica com o protocolo Ellestad. </p>
    <p><bold>RESULTADOS:</bold> A vers&#227;o curta do question&#225;rio Rose de angina dos 116 indiv&#237;duos submetidos ao teste de esfor&#231;o em esteira ergom&#233;trica mostrou 89,7% de acur&#225;cia, 25% de sensibilidade, 92% de especificidade, 10% de valor preditivo positivo, 97,2% de valor preditivo negativo e 3,1 de raz&#227;o de probabilidade positiva e 0,82 de raz&#227;o de probabilidade negativa. </p>
    <p><bold>CONCLUS&#195;O:</bold> A vers&#227;o em portugu&#234;s com os tr&#234;s itens do question&#225;rio Rose de angina &#233; adequada para objetivos epidemiol&#243;gicos.</p>
    <p><bold>Palavras-chave:</bold> Question&#225;rios; angina pectoris / epidemiologia; doen&#231;as cardiovasculares; doen&#231;a da art&#233;ria coronariana.</p>
    <p>
      <bold>Introdu&#231;&#227;o</bold>
    </p>
    <p>A estimativa da preval&#234;ncia e incid&#234;ncia de angina <italic>pectoris</italic> &#233; um desafio para a epidemiologia cardiovascular. Estudos epidemiol&#243;gicos abordando tend&#234;ncias temporais e compara&#231;&#245;es internacionais de taxas de mortalidade s&#227;o uma ferramenta relevante e de baixo custo para estimar o impacto da Doen&#231;a Arterial Coronariana (DAC), como morte s&#250;bita e infarto do mioc&#225;rdio<sup>1</sup>. Contudo, essas descri&#231;&#245;es de taxas de mortalidade n&#227;o nos permitem mesurar um ponto-chave do amplo espectro da DAC: a angina <italic>pectoris</italic> est&#225;vel. Atualmente existem alguns instrumentos para quantificar a angina <italic>pectoris</italic> como registros m&#233;dicos de cuidados prim&#225;rios de sa&#250;de; frequ&#234;ncia de prescri&#231;&#227;o de nitratos; autorrelato de experi&#234;ncia recente ou n&#227;o de angina e o "Question&#225;rio Rose de Angina"<sup>2</sup>. Em 1962, Geoffrey A. Rose (1926 &#150; 1993), medico brit&#226;nico e professor de epidemiologia, desenvolveu uma nova ferramenta para pesquisas e estudos epidemiol&#243;gicos &#150; mas n&#227;o para uso cl&#237;nico: um teste com sete quest&#245;es incluindo o diagrama de um t&#243;rax masculino. Ele permitia estimar a preval&#234;ncia de angina <italic>pectoris</italic> est&#225;vel. Para valida&#231;&#227;o, ele comparou as respostas de volunt&#225;rios com uma avalia&#231;&#227;o cl&#237;nica de dois cardiologistas seniores como o padr&#227;o-ouro (teste de refer&#234;ncia). Mais tarde, esse question&#225;rio foi recomendado pela Organiza&#231;&#227;o Mundial de Sa&#250;de (OMS) como instrumento-geral para determina&#231;&#227;o de preval&#234;ncia de angina, e desde ent&#227;o &#233; conhecido como "Question&#225;rio de angina da OMS/Rose"<sup>3</sup>.</p>
    <p>At&#233; o ano de 2005, a aplica&#231;&#227;o do question&#225;rio de Rose foi identificada em 74 estudos de 13.331 casos de angina em mulheres e 11.511 casos em homens de 31 pa&#237;ses. A preval&#234;ncia de angina variou amplamente nos diferentes cen&#225;rios, de 0,73% a 14,4% em mulheres e de 0,76% a 15,1% em homens<sup>4</sup>. No Brasil, a vers&#227;o completa do question&#225;rio Rose foi aplicada em Pelotas, Rio Grande do Sul, em 1.680 indiv&#237;duos com idade acima de 40 anos, mostrando uma preval&#234;ncia de angina de 8,2%<sup>5</sup>. </p>
    <p>Em 2003, Lawlor e cols.<sup>6</sup> propuseram uma vers&#227;o curta do question&#225;rio de angina da OMS/Rose, focada em apenas tr&#234;s quest&#245;es que tratavam de dor no peito ap&#243;s esfor&#231;o. Eles compararam os dois question&#225;rios em mulheres usando como padr&#227;o-ouro dados provenientes de consultas de cuidados prim&#225;rios para sintomas de angina dos &#250;ltimos cinco anos. O question&#225;rio curto foi mais sens&#237;vel (de 33% para 51,8%) e levemente menos espec&#237;fico (de 93,8% para 89,4%) que a vers&#227;o original do question&#225;rio Rose. Eles conclu&#237;ram que a aplica&#231;&#227;o dos tr&#234;s itens desse question&#225;rio de angina pode ser adequada para estudos epidemiol&#243;gicos<sup>6</sup>. Mais recentemente, o estudo Smart na Holanda, em um acompanhamento de 4,6 anos de 7.916 pacientes consecutivos com diagn&#243;stico cl&#237;nico da doen&#231;a ou com fatores de risco cardiovascular, comparou o question&#225;rio Rose padr&#227;o e a sua vers&#227;o curta. A capacidade discriminat&#243;ria das duas abordagens para eventos coronarianos foi avaliada por meio de &#225;reas sob as curvas ROC (Receiver Operating Characteristic) com intervalos similares (0,708-0,726)<sup>7</sup>. Durante uma avalia&#231;&#227;o de 23 anos em uma coorte de 30 mil noruegueses de meia-idade aparentemente saud&#225;veis, os tr&#234;s itens do question&#225;rio Rose identificaram DAC desconhecida na linha basal com raz&#245;es de risco para previs&#227;o de s&#237;ndrome coronariana aguda similares ao aumento nos n&#237;veis de colesterol total e press&#227;o arterial sist&#243;lica<sup>8</sup>.</p>
    <p>O objetivo desse estudo &#233; validar a vers&#227;o curta em portugu&#234;s do "Question&#225;rio de angina da OMS/Rose" em uma amostra usando o teste em esteira ergom&#233;trica como padr&#227;o-ouro para futuras aplica&#231;&#245;es em pesquisas e estudos de coorte, assim como no atual Estudo Brasileiro Longitudinal de Sa&#250;de do Adulto (ELSA-Brasil)<sup> 9</sup>. </p>
    <p>
      <bold>M&#233;todos</bold>
    </p>
    <p>Um total de 126 pacientes consecutivos de um ambulat&#243;rio cl&#237;nico na cidade de S&#227;o Paulo, com idades entre 40 e 74 anos com indica&#231;&#227;o para o teste em esteira ergom&#233;trica, foi convidado a participar do estudo. Os crit&#233;rios de exclus&#227;o foram autorrelato de experi&#234;ncia de angina, hospitaliza&#231;&#227;o em virtude da s&#237;ndrome coronariana aguda e a recusa em participar do estudo. Como os pesquisadores n&#227;o interferiram na sele&#231;&#227;o dos indiv&#237;duos tratados em um hospital-escola da comunidade, n&#243;s esper&#225;vamos uma boa valida&#231;&#227;o externa dos resultados. A amostra incluiu pacientes com diferentes probabilidades de apresentar angina; o n&#250;mero de participantes da amostra foi calculado considerando uma sensibilidade esperada de 30%, uma amplitude total de 0,30 e um intervalo de confian&#231;a de 95%; considerando esses par&#226;metros, o tamanho da amostra foi estimado em 72 pacientes<sup>10</sup>.</p>
    <p>A vers&#227;o curta do "Question&#225;rio de Angina da OMS/Rose" foi aplicada com as tr&#234;s primeiras quest&#245;es da vers&#227;o original<sup>4</sup> traduzidas e adaptadas para o portugu&#234;s brasileiro para uso no Estudo Brasileiro Longitudinal de Sa&#250;de do Adulto (ELSA-Brasil)<sup>9</sup>. A angina era positiva quando a resposta era afirmativa para a quest&#227;o: "Voc&#234; alguma vez teve qualquer dor ou desconforto em seu peito?<italic>"</italic> e quando a resposta era afirmativa para uma das seguintes quest&#245;es: "Voc&#234; tem dor quando anda em ritmo normal em piso nivelado?" ou "Voc&#234; tem dor quando est&#225; subindo uma eleva&#231;&#227;o ou andando apressadamente?"</p>
    <p>Todos os participantes foram submetidos ao teste de exerc&#237;cio em esteira ergom&#233;trica com o uso do protocolo de Ellestad<sup>10</sup>. O teste era considerado aceit&#225;vel se o indiv&#237;duo atingia 85% da taxa m&#225;xima de batimentos card&#237;acos prevista para a idade e positivo para isquemia quando n&#227;o havia depress&#227;o horizontal do segmento ST, medido no ponto Y <underline>&gt;</underline> 1,0 mm em homens e 1,5 mm em mulheres; ou descendente, medido no ponto J <underline>&gt;</underline> 1,0 mm em homens e 1,5 mm em mulheres; ou lento ascendente, medido no ponto Y, <underline>&gt;</underline> 1,5 mm em homens e <underline>&gt;</underline> 2,0 mm em mulheres. </p>
    <p>A sensibilidade, especificidade, valores preditivos positivos e negativos, raz&#227;o de probabilidade positiva e negativa e acur&#225;cia da vers&#227;o curta do question&#225;rio de angina OMS/Rose foram calculados usando o teste em esteira ergom&#233;trica como padr&#227;o-ouro para angina <italic>pectoris</italic> em uma tabela 2 x 2. </p>
    <p>O estudo foi aprovado pelo comit&#234; institucional e todos os participantes concordaram em participar assinando o formul&#225;rio de consentimento livre e informado. </p>
    <p>
      <bold>Resultados</bold>
    </p>
    <p>Entre os 126 indiv&#237;duos com idade m&#233;dia de 53,6 anos (desvio padr&#227;o &#177;7,0) submetidos ao teste em esteira ergom&#233;trica, 116 (92,1%) apresentaram um teste conclusivo. Os homens representaram 57% da amostragem. Um ter&#231;o da amostragem apresentava risco de 10 anos de DAC maior que 10% pelo Score de Risco de Framingham. O tempo m&#233;dio entre o question&#225;rio de angina e o exerc&#237;cio ergom&#233;trico foi de 42,2 dias (desvio padr&#227;o de &#177; 38,8). Dez pessoas (8,6%) responderam ao question&#225;rio positivamente para a presen&#231;a de angina, e foi detectada isquemia em quatro indiv&#237;duos (3,4%) no teste em esteira ergom&#233;trica. A <xref ref-type="table" rid="a12tab01">Tabela 1</xref> mostra o question&#225;rio de angina dos 116 indiv&#237;duos submetidos ao exerc&#237;cio ergom&#233;trico mostrando 89,7% de acur&#225;cia (IC95% 84,2% - 95,2%), 25% de sensibilidade (IC95% 17,2% - 32,8%), 92,0% de especificidade (IC95% 88,1% - 95,9%), 10,0% de valor preditivo positivo, 97,2% (IC95% 94,2% - 100%) de valor preditivo negativo (IC95% 96,9% - 97,5%), 3,1 de raz&#227;o de probabilidade positiva (IC95% 2,1 - 16,6) e 0,82 de raz&#227;o de probabilidade negativa (IC95% 0,75 - 4,43).</p>
    <p content-type="asset">
      <table-wrap id="a12tab01">
        <graphic xlink:href="1678-4170-abc-99-05-1056-00012-gt01.jpg"/></table-wrap>
    </p>
    <p>
      <bold>Discuss&#227;o</bold>
    </p>
    <p>Este estudo avaliou a validade do "Question&#225;rio de angina OMS/Rose" para o diagn&#243;stico de doen&#231;a arterial coronariana em indiv&#237;duos sem doen&#231;a cardiovascular clinicamente aparente. Nossas descobertas, a sensibilidade de 25% e especificidade de 92%, s&#227;o muito similares aos dados relatados anteriormente por Lawlor e cols. com uma popula&#231;&#227;o feminina<sup>6</sup>. Houve diferen&#231;as entre os dois estudos, relacionadas &#224; amostragem e teste de refer&#234;ncia. Nossa amostra &#233; mais jovem e composta por indiv&#237;duos de ambos os sexos. Utilizamos o exerc&#237;cio em esteira ergom&#233;trica como teste de refer&#234;ncia, e eles consideraram os registros m&#233;dicos em um per&#237;odo de cinco anos como padr&#227;o-ouro. No entanto, nessa valida&#231;&#227;o, o question&#225;rio de angina OMS/Rose apresentou alta especificidade e baixa sensibilidade, como esperado para um question&#225;rio usado em pesquisa epidemiol&#243;gica. </p>
    <p>Sempre que um question&#225;rio &#233; aplicado a uma grande amostra, o objetivo &#233; diminuir custos e quest&#245;es de seguran&#231;a. &#201; invi&#225;vel submeter milhares de participantes a avalia&#231;&#245;es cardiol&#243;gicas e cintilografia. Com base nessa premissa, a preval&#234;ncia da doen&#231;a na popula&#231;&#227;o amostrada e o padr&#227;o-ouro usado s&#227;o pontos cr&#237;ticos para avalia&#231;&#227;o de um question&#225;rio com objetivos epidemiol&#243;gicos. &#201; importante enfatizar que tanto m&#233;dicos quanto epidemiologistas precisam de uma defini&#231;&#227;o precisa da doen&#231;a; contudo, eles est&#227;o abordando diferentes objetivos com indiv&#237;duos e popula&#231;&#227;o, respectivamente. M&#233;dicos trabalham com uma grande variedade de sintomas para uma mesma doen&#231;a e usam uma vasta gama de defini&#231;&#245;es de doen&#231;as que tenta cobrir todas as apresenta&#231;&#245;es cl&#237;nicas. O epidemiologista usa defini&#231;&#245;es mais restritas de doen&#231;as, pois querem comparar seus resultados com os dados obtidos em diferentes lugares e per&#237;odos. Assim, os m&#233;dicos tentam trabalhar com defini&#231;&#245;es de doen&#231;as altamente sens&#237;veis, e os epidemiologistas tentam trabalhar com defini&#231;&#245;es mais espec&#237;ficas. Isso explica porque question&#225;rios usados em estudos epidemiol&#243;gicos frequentemente apresentam uma alta especificidade e baixa sensibilidade<sup>2</sup>. Escolhemos uma popula&#231;&#227;o razoavelmente homog&#234;nea com pacientes que n&#227;o tinham DAC confirmado &#150; infarto pr&#233;vio do mioc&#225;rdio e/ou revasculariza&#231;&#227;o coronariana &#150; e volunt&#225;rios aparentemente saud&#225;veis. Nosso estudo foi o primeiro no Brasil a usar a vers&#227;o curta do question&#225;rio Rose de angina, o mesmo que foi aplicado no Estudo Longitudinal Brasileiro de Sa&#250;de Adulta (ELSA-Brasil)<sup>9</sup>. Ele pode ser usado para avaliar a preval&#234;ncia em pesquisas e a incid&#234;ncia de angina em estudos longitudinais<sup>2</sup>. </p>
    <p>
      <bold>Conclus&#227;o</bold>
    </p>
    <p>A vers&#227;o curta do Question&#225;rio de Angina OMS/Rose com tr&#234;s quest&#245;es sobre dor no peito ap&#243;s exerc&#237;cio pode ser aplicada em estudos epidemiol&#243;gicos.</p>
    <p>
      <fn id="end" fn-type="corresp">
        <p>Correspond&#234;ncia:</p>
        <p> Paulo Andrade Lotufo </p>
        <p> Av. Lineur Prestes, 2565, Cidade Universit&#225;ria </p>
        <p> CEP 05508-000, S&#227;o Paulo, SP - Brasil </p>
        <p> E-mail: </p>
        <p><email xlink:href="palotufo@cardiol.br">palotufo@cardiol.br</email>, </p>
        <p>
          <email xlink:href="palotufo@hu.usp.br">palotufo@hu.usp.br</email>
        </p>
      </fn>
    </p>
    <p>Artigo recebido em 21/01/12; revisado em 24/01/12; aceito em 06/07/12.</p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation>1. Lotufo PA. [Premature mortality from heart diseases in Brazil: a comparison with other countries]. Arq Bras Cardiol. 1998;70(5):321-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Premature mortality from heart diseases in Brazil: a comparison with other countries</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>321</fpage>
          <lpage>5</lpage>
          <issue>5</issue>
          <volume>70</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Lotufo</surname>
              <given-names>PA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B2">
        <mixed-citation>2. Russell M, Williams M, May E, Stewart S. The conundrum of detecting stable angina pectoris in the community setting. Nat Rev Cardiol. 2010;7(2):106-13.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The conundrum of detecting stable angina pectoris in the community setting</article-title>
          <source>Nat Rev Cardiol</source>
          <date>
            <year>2010</year>
          </date>
          <fpage>106</fpage>
          <lpage>13</lpage>
          <issue>2</issue>
          <volume>7</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Russell</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>May</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Stewart</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B3">
        <mixed-citation>3. Rose GA. The diagnosis of ischaemic heart pain and intermittent claudication in fields surveys. Bull World Health Organ. 1962;27:645-58.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The diagnosis of ischaemic heart pain and intermittent claudication in fields surveys</article-title>
          <source>Bull World Health Organ</source>
          <date>
            <year>1962</year>
          </date>
          <fpage>645</fpage>
          <lpage>58</lpage>
          <volume>27</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Rose</surname>
              <given-names>GA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4. Hemingway H, Langenberg C, Damant J, Frost C, Py&#246;r&#228;l&#228; K, Barret-Connor E. Prevalence of angina in women versus men: a systematic review and meta-analysis of international variations across 31 countries. Circulation. 2008;117(12):1526-36.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Prevalence of angina in women versus men: a systematic review and meta-analysis of international variations across 31 countries</article-title>
          <source>Circulation</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>1526</fpage>
          <lpage>36</lpage>
          <issue>12</issue>
          <volume>117</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hemingway</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Langenberg</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Damant</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Frost</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Py&#246;r&#228;l&#228;</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Barret-Connor</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>5  Alves L, Cesar JA, Horta BL. Prevalence of angina pectoris in Pelotas, south of Brazil. Arq Bras Cardiol. 2010;95(2):179-85.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Prevalence of angina pectoris in Pelotas, south of Brazil</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2010</year>
          </date>
          <fpage>179</fpage>
          <lpage>85</lpage>
          <issue>2</issue>
          <volume>95</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Alves</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Cesar</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Horta</surname>
              <given-names>BL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>6. Lawlor DA. Adamson J, Ebrahim S. Performance of the WHO Rose angina questionnaire in post-menopausal women: are all of the questions necessary? J Epidemiol Community Health. 2003;57(7):538-41.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Performance of the WHO Rose angina questionnaire in post-menopausal women: are all of the questions necessary?</article-title>
          <source>J Epidemiol Community Health</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>538</fpage>
          <lpage>41</lpage>
          <issue>7</issue>
          <volume>57</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Lawlor</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Adamson</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ebrahim</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <mixed-citation>7. Achterberg S, Soedamah-Muthu S, Cramer MJ, Kappelle L, van der Graaf Y, Algra A; SMART Study Group. Prognostic value of the Rose questionnaire: a validation with future coronary events in the SMART study. Eur J Prev Cardiol. 2012;19(1):5-14.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Prognostic value of the Rose questionnaire: a validation with future coronary events in the SMART study</article-title>
          <source>Eur J Prev Cardiol</source>
          <date>
            <year>2012</year>
          </date>
          <fpage>5</fpage>
          <lpage>14</lpage>
          <issue>1</issue>
          <volume>19</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Achterberg</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Soedamah-Muthu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Cramer</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Kappelle</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>van der Graaf</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Algra</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <mixed-citation>8. Graff-Iversen S, Selmer R, L&#248;chen ML. Rose angina predicts 23-year coronary heart disease mortality in women and men aged 40-49 years. Heart. 2008;94(4):482-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Rose angina predicts 23-year coronary heart disease mortality in women and men aged 40-49 years</article-title>
          <source>Heart</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>482</fpage>
          <lpage>6</lpage>
          <issue>4</issue>
          <volume>94</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Graff-Iversen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Selmer</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>L&#248;chen</surname>
              <given-names>ML</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <mixed-citation>9. Aquino EM, Barreto SM, Bensenor IM, Carvalho MS, Chor D, Duncan BB, et al. Brazilian Longitudinal Study of Adult Health (ELSA-Brasil): objectives and design. Am J Epidemiol. 2012;175(4):315-24.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Brazilian Longitudinal Study of Adult Health (ELSA-Brasil): objectives and design</article-title>
          <source>Am J Epidemiol</source>
          <date>
            <year>2012</year>
          </date>
          <fpage>315</fpage>
          <lpage>24</lpage>
          <issue>4</issue>
          <volume>175</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Aquino</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Barreto</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Bensenor</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>Carvalho</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Chor</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Duncan</surname>
              <given-names>BB</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B10">
        <mixed-citation>10. Browner WS, Newman TB, Cummings SR, Hulley SB. Estimating sample size and power: the nitty-gritty. In: Hulley SB, Cummings SR, Browner WS, Grady D, Hearst N, Newman TB. Designing clinical reasearch. 2<sup>nd</sup> ed. Philadelphia: Lippincott Williams &amp; Wilkins; 2007. p. 65.</mixed-citation>
        <element-citation publication-type="book">
          <source>Designing clinical reasearch</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>65</fpage>
          <person-group person-group-type="author">
            <name>
              <surname>Browner</surname>
              <given-names>WS</given-names>
            </name>
            <name>
              <surname>Newman</surname>
              <given-names>TB</given-names>
            </name>
            <name>
              <surname>Cummings</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Hulley</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Hulley</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Cummings</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Browner</surname>
              <given-names>WS</given-names>
            </name>
            <name>
              <surname>Grady</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Hearst</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Newman</surname>
              <given-names>TB</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Brief Communication</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Validation of the short-version of Rose angina questionnaire in Brazil</article-title>
      </title-group>
      <abstract xml:lang="en">
        <p>BACKGROUND: Stable angina pectoris is a serious condition with few epidemiological studies in Brazil. OBJECTIVE: To validate the short-version of the Rose angina questionnaire in Brazilian Portuguese for its implementation in surveys and longitudinal studies. METHODS: A total of 116 consecutive patients from an outpatient clinic without prior myocardial infarction and/or coronary revascularization were enrolled for application of three questions of the Rose angina questionnaire addressing chest pain after exertion. We used the treadmill test as the gold standard with the Ellestad protocol. RESULTS: The short-version of the Rose angina questionnaire of the 116 subjects submitted to the exercise treadmill test disclosed 89.7% of accuracy, 25% of sensitivity, 92.0% of specificity, 10.0% of positive predictive value, 97.2% of negative predictive value, and 3.1 of positive likelihood ratio and 0.82 of negative likelihood ratio. CONCLUSION: The Portuguese version with three items of the Rose angina questionnaire is suitable for epidemiological purposes.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>Questionnaires</kwd>
        <kwd>angina pectoris</kwd>
        <kwd>cardiovascular diseases</kwd>
        <kwd>coronary artery disease</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>BRIEF COMMUNICATION</bold>
      </p>
      <p><undefined id="tx-body2"/>Validation of the short-version of Rose angina questionnaire in Brazil</p>
      <p>
        <bold>Maria-Socorro Bastos<sup>I</sup>; Paulo A. Lotufo<sup>II, III</sup>; Aristarcho L. Whitaker<sup>II</sup>; Isabela M. Bensenor<sup>II, III</sup></bold>
      </p>
      <p><sup>I</sup>Universidade Federal do Par&#225;, Bel&#233;m, PA - Brazil</p>
      <p><sup>II</sup>Hospital Universit&#225;rio da USP, S&#227;o Paulo, SP - Brazil</p>
      <p><sup>III</sup>Faculdade de Medicina da USP, S&#227;o Paulo, SP - Brazil</p>
      <p>Mailing Address</p>
      <p>
        <bold>ABSTRACT</bold>
      </p>
      <p><bold>BACKGROUND: </bold>Stable angina pectoris is a serious condition with few epidemiological studies in Brazil.</p>
      <p><bold>OBJECTIVE: </bold>To validate the short-version of the Rose angina questionnaire in Brazilian Portuguese for its implementation in surveys and longitudinal studies.</p>
      <p><bold>METHODS: </bold>A total of 116 consecutive patients from an outpatient clinic without prior myocardial infarction and/or coronary revascularization were enrolled for application of three questions of the Rose angina questionnaire addressing chest pain after exertion. We used the treadmill test as the gold standard with the Ellestad protocol.</p>
      <p><bold>RESULTS: </bold>The short-version of the Rose angina questionnaire of the 116 subjects submitted to the exercise treadmill test disclosed 89.7% of accuracy, 25% of sensitivity, 92.0% of specificity, 10.0% of positive predictive value, 97.2% of negative predictive value, and 3.1 of positive likelihood ratio and 0.82 of negative likelihood ratio.</p>
      <p><bold>CONCLUSION:</bold> The Portuguese version with three items of the Rose angina questionnaire is suitable for epidemiological purposes.</p>
      <p><bold>Keywords:</bold> Questionnaires; angina pectoris / epidemiology; cardiovascular diseases; coronary artery disease.</p>
      <p>
        <bold>Introduction</bold>
      </p>
      <p>The estimation of prevalence and incidence of angina pectoris has been a challenge for cardiovascular epidemiology. Epidemiological studies addressing temporal trends and international comparison of mortality death rates are a relevant and low-cost tool for estimation of the burden of Coronary Heart Disease (CHD), such as sudden death and myocardial infarction<sup>1</sup>. However, these descriptions of death rates do not permit to measure one pivotal point of the broad spectrum of CHD: stable angina pectoris. Nowadays, there are some instruments to quantify angina pectoris as primary-care medical records; frequency of prescription of nitrates; self-report of current or ever-experienced angina, and the "Rose Angina Questionnaire"<sup>2</sup>. In 1962, Geoffrey A. Rose (*1926-&#134;1993), a British physician and professor of epidemiology developed a new tool for surveys and epidemiological studies -but not for clinical use-: one test with seven questions including the diagram of a male thorax. It allowed estimating the prevalence of stable angina pectoris. For validation, he compared the answers from volunteers with a clinical evaluation of two senior cardiologists as the gold standard (reference test). Later, this questionnaire was recommended by the World Health Organization (WHO) as a general instrument for the determination of angina prevalence, and since then it has been known as "WHO-Rose Angina Questionnaire"<sup>3</sup>.</p>
      <p>Until the year 2005, the application of the Rose questionnaire was identified in 74 studies of 13,331 angina cases in women and 11,511 cases in men from 31 countries. Angina prevalence varied widely across these different settings from 0.73% to 14.4% in women and from 0.76% to 15.1% in men<sup>4</sup>. In Brazil, the full version of the Rose questionnaire was applied in Pelotas, Rio Grande do Sul to 1680 individuals older than 40 years showing a prevalence of angina of 8.2%<sup>5</sup>. </p>
      <p>In 2003, Lawlor et al.<sup>6</sup> proposed a short-version of the WHO-Rose angina questionnaire that focused on only three questions dealing with chest pain after exertion. They compared the two questionnaires in women using as the gold standard data from a primary care consultation for angina symptoms within the past five years. The short-questionnaire was more sensitive (from 33% to 51.8%) and slightly less specific (from 93.8% to 89.4%) than the original version of the Rose questionnaire. They concluded that applying the three-item Rose angina questionnaire can be suitable for epidemiological studies<sup>6</sup>. More recently, the SMART study in Netherlands, a 4.6-year follow-up of 7,916 consecutive patients with clinically diagnosed disease or cardiovascular risk factors, compared the standard Rose questionnaire and its short-version. Discriminatory ability of both approaches for coronary events was assessed with areas under the receiver-operator characteristics (ROC) curves with similar range (0.708-0.726)<sup>7</sup>. During a 23-year evaluation, in a cohort of 30,000 middle-aged apparently healthy Norwegians, the three-item Rose questionnaire identified unknown CHD at baseline with hazard ratios to predict acute coronary syndrome that were similar to increase in total cholesterol and systolic blood pressure levels<sup>8</sup>.</p>
      <p>The aim of this study is to validate of the Portuguese short-version of "WHO Rose angina questionnaire" in a sample using the exercise treadmill test as the gold standard for future application in surveys and cohort studies as in the ongoing Brazilian Longitudinal Study of Adult Health (ELSA-Brazil)<sup>9</sup>.</p>
      <p>
        <bold>Methods</bold>
      </p>
      <p>A total of 126 consecutive patients from an outpatient clinic in the city of Sao Paulo, aged 40-74 years with an indication for a treadmill test were invited to participate in the study. Exclusion criteria were self-report of ever-experienced angina, hospitalization due to acute coronary syndrome and refusal to participate. As the researchers did not interfere in the selection of subjects treated at an academic community-based hospital, we expected a good external validity of the results. The sample included patients with different probabilities of having angina; the number of participants was calculated considering an expected sensitivity of 30%, a total width of 0.30 and a 95% confidence interval; number of participants of the sample was calculated considering an expected sensitivity of 30%, a total width of 0.30 and a 95% confidence interval; considering these parameters, a sample size of 72 patients was estimated<sup>10</sup>.</p>
      <p>The short version of "WHO Rose Angina Questionnaire" was applied with the first three questions of the original version<sup>4</sup> translated and adapted to Brazilian Portuguese for use in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)<sup>9</sup>. Angina was positive when the answer was positive for the question: <italic>"Do you ever have any pain or discomfort in your chest?"</italic> and when the answer was affirmative for one of the following questions: <italic>"Do you get it when you walk at an ordinary pace on the level?"</italic> or "<italic>Do you get it when you walk up hill or hurry?</italic>"</p>
      <p>All participants were submitted to an exercise treadmill testing performed with the use of the Ellestad protocol<sup>10</sup>. The test was considered as acceptable if the subject achieved 85% of the age-predicted maximum heart rate and it was positive for ischemia when there was horizontal ST segment depression, measured on Y point, <underline>&gt;</underline>1.0mm in men e 1.5 mm in women, or descendent, measured on J point, <underline>&gt;</underline>1.0mm in men and 1.5 mm in women, or slow ascending, measured at the Y point, <underline>&gt;</underline> 1.5 mm in men e <underline>&gt;</underline> 2.0 mm in women.</p>
      <p>Sensitivity, specificity, positive and negative predictive values, positive and negative likelihood ratios and accuracy of the short form of the WHO Rose angina questionnaire were calculated using the exercise treadmill test as the gold standard for angina pectoris in a 2x2 table.</p>
      <p>The study was approved by the Institutional Boarding Committee, and all participants agreed to participate and signed the informed consent.</p>
      <p>
        <bold>Results</bold>
      </p>
      <p>Among the 126 subjects with a mean age of 53.6 (standard deviation &#177;7.0) years submitted to treadmill test, 116 (92.1%) presented a conclusive test. Men were 57% of the sample. One third of the sample had a 10-year risk of CHD higher than 10% by the Framingham Score Risk. Mean time between angina questionnaire and exercise treadmill test was 42.2 (standard deviation &#177;38.8) days. Ten people (8.6%) answered the questionnaire positively for the presence of angina, and four subjects (3.4%) had ischemia detected at the treadmill test. <xref ref-type="table" rid="en_a12tab01-body2">Table 1</xref> shows that the angina questionnaire of the 116 subjects submitted to exercise treadmill test disclosing 89.7% of accuracy (95% CI, 84.2% - 95.2%), 25% of sensitivity (95% CI, 17.2%-32.8%), 92.0% of specificity (95% CI, 88.1%-95,.9%), 10.0% of positive predictive value , 97.2% (95% CI, 94.2% - 100%) of negative predictive value (95% CI, 96.9% - 97.5%), 3.1 of positive likelihood ratio (95% CI, 2.1 - 16.6) and 0.82 of negative likelihood ratio (95% CI, 0.75 &#150; 4.43).</p>
      <p content-type="asset">
        <table-wrap id="en_a12tab01-body2">
          <graphic xlink:href="1678-4170-abc-99-05-1056-00012-gt01-en.jpg"/></table-wrap>
      </p>
      <p>
        <bold>Discussion</bold>
      </p>
      <p>This study evaluated the validity of "WHO Rose angina questionnaire" for the diagnosis of coronary heart disease for individuals without clinically apparent cardiovascular disease. Our findings, the sensitivity of 25% and specificity of 92% is very similar to previous data reported by Lawlor et al. with a female population<sup>6</sup>. There were differences between these two studies related to sampling and reference test. Our sample is younger, and it consisted of individuals of both genders. We used the treadmill test as reference and they considered the medical records within the last five-years as the gold standard. However, in this validation, WHO Rose angina questionnaire showed high specificity and low sensitivity, as expected for a questionnaire used in epidemiologic research. </p>
      <p>Every time a questionnaire is applied to a large sample, the objective is to decrease costs and safety concerns. It is impracticable to refer thousands of participants to cardiologist assessment and scintigraphy. Based on this assumption, the prevalence of disease in the population sampled and the gold standard used are the critical points for evaluation of a questionnaire for epidemiological purposes. It is appropriate to emphasize that both physicians and epidemiologists need an accurate disease definition; however they are addressing different goals with individuals, and population, respectively. Physicians work with a great variety of symptoms for the same disease, and they use broad definitions of diseases that try to cover all clinical presentations. Epidemiologists use a more restricted definition of diseases, as they want to compare their results with data obtained in different places and periods. Thus, physicians try to work with highly sensitive definitions of disease and epidemiologists try to work with more specific definitions. This explains why questionnaires used in epidemiological studies often have high specificity and low sensitivity<sup>2</sup>. We chose a relatively homogenous population that consisted of patients who had not had confirmed CHD - previous myocardial infarction and/or coronary revascularization - and apparently healthy volunteers.</p>
      <p>Our study was the first in Brazil that used the short version of Rose angina questionnaire, the same that has been applied in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)<sup>9</sup>. It can be used to evaluate prevalence in surveys and for incidence of angina in longitudinal studies<sup>2</sup>. </p>
      <p>
        <bold>Conclusion</bold>
      </p>
      <p>A short-version of the "WHO-Rose Angina Questionnaire" with three questions about chest pain after exertion can be applied in epidemiological studies.</p>
      <p>
        <bold>References</bold>
      </p>
    </body>
  </sub-article>
</article>
